Fig. 2From: Efficacy of omalizumab in children, adolescents, and adults with severe allergic asthma: a systematic review, meta-analysis, and call for new trials using current guidelines for assessment of severe asthmaRate ratio for annual exacerbation rate among adultsBack to article page